Literature DB >> 16014371

Life-threatening interaction between complementary medicines: cyanide toxicity following ingestion of amygdalin and vitamin C.

Jonathan Bromley1, Brett G M Hughes, David C S Leong, Nicholas A Buckley.   

Abstract

OBJECTIVE: To describe a case of severe accidental cyanide poisoning following a single ingestion of amygdalin with therapeutic intent. CASE
SUMMARY: A 68-year-old patient with cancer presented to the emergency department shortly after her first dose (3 g) of amygdalin with a reduced Glasgow Coma Score, seizures, and severe lactic acidosis requiring intubation and ventilation. The patient also ingested 4800 mg of vitamin C per day. She responded rapidly to hydroxocobalamin treatment. The adverse drug reaction was rated probable on the Naranjo probability scale. DISCUSSION: Amygdalin and laetrile (a synthetic form of amygdalin) are commonly used as complementary or alternative medicine (CAM) for the treatment of cancer. Vitamin C is known to increase the in vitro conversion of amygdalin to cyanide and reduce body stores of cysteine, which is used to detoxify cyanide. Amygdalin has been used for decades by patients with cancer who are seeking alternative therapies, and severe reactions have not been reported with this dose. An interaction with vitamin C is a plausible explanation for this life-threatening response.
CONCLUSIONS: This case highlights the fact that CAMs can produce life-threatening toxicity. This case also adds a further note of caution, namely, the potential for serious interactions between CAMs, particularly where there is no tradition of concomitant use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014371     DOI: 10.1345/aph.1E634

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  12 in total

Review 1.  Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology.

Authors:  D Seger; K Barker; C McNaughton
Journal:  Clin Toxicol (Phila)       Date:  2013-06-18       Impact factor: 4.467

2.  Identifying unproven cancer treatments on the health web: addressing accuracy, generalizability and scalability.

Authors:  Yin Aphinyanaphongs; Lawrence D Fu; Constantin F Aliferis
Journal:  Stud Health Technol Inform       Date:  2013

3.  Effects of short-term heating on total polyphenols, anthocyanins, antioxidant activity and lectins of different parts of dwarf elder (Sambucus ebulus L.).

Authors:  Pilar Jimenez; Patricia Cabrero; José E Basterrechea; Jesús Tejero; Damian Cordoba-Diaz; Manuel Cordoba-Diaz; Tomas Girbes
Journal:  Plant Foods Hum Nutr       Date:  2014-06       Impact factor: 3.921

4.  Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Authors:  Sebastian J Padayatty; Andrew Y Sun; Qi Chen; Michael Graham Espey; Jeanne Drisko; Mark Levine
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

Review 5.  Vitamin C: the known and the unknown and Goldilocks.

Authors:  S J Padayatty; M Levine
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

6.  An unusual presentation of chronic cyanide toxicity from self-prescribed apricot kernel extract.

Authors:  Alex Konstantatos; Malini Shiv Kumar; Aidan Burrell; Joel Smith
Journal:  BMJ Case Rep       Date:  2017-09-11

Review 7.  Laetrile for cancer: a systematic review of the clinical evidence.

Authors:  Stefania Milazzo; Stephane Lejeune; Edzard Ernst
Journal:  Support Care Cancer       Date:  2006-11-15       Impact factor: 3.359

8.  Physician Beware: Severe Cyanide Toxicity from Amygdalin Tablets Ingestion.

Authors:  Tam Dang; Cham Nguyen; Phu N Tran
Journal:  Case Rep Emerg Med       Date:  2017-08-24

Review 9.  Laetrile treatment for cancer.

Authors:  Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

Review 10.  Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.

Authors:  Xue-Qing Hu; Yang Sun; Eric Lau; Ming Zhao; Shi-Bing Su
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.